Dental caries status of patients with schizophrenia in Seville, Spain: a case-control study by Velasco Ortega, Eugenio et al.
Velasco‑Ortega et al. BMC Res Notes  (2017) 10:50 
DOI 10.1186/s13104‑016‑2368‑9
RESEARCH ARTICLE
Dental caries status of patients 
with schizophrenia in Seville, Spain: a case–
control study
Eugenio Velasco‑Ortega1*, L. Monsalve‑Guil2, I. Ortiz‑Garcia2, A. Jimenez‑Guerra2, J. Lopez‑Lopez3 
and J. J. Segura‑Egea2
Abstract 
Background: The aim of this study was to assess the dental status (DMFT) in patients with schizophrenia compared 
with a control group.
Material: In this case–control study, 50 patients with schizophrenia attended in the Psychiatric Unit at the Virgen 
Macarena University Hospital of Seville were compared with 50 people (without systemic diseases and not taking 
psychotropic drugs) in a control group attended in the School of Dentistry of Seville. Decayed, missing and filled teeth 
(DMFT) were assessed according to the World Health Organization WHO criteria.
Results: Patients with schizophrenia showed a decayed teeth (DT) score of 7.26 ± 5.69 compared with 6.50 ± 4.37 
for patients the control group. These differences were significant and suggest that dental caries are most prevalent 
in patients with schizophrenia. People who smoked showed significantly higher DT scores in both groups. Among 
patients with schizophrenia, smokers scored 9.34 ± 5.42 compared with 4.38 ± 4.82 for non‑smokers. Among the 
healthy controls, smokers scored 6.88 ± 4.85 compared with 6.12 ± 3.85 for non‑smokers (p < 0.05). Patients with 
schizophrenia showed a missing teeth (MT) score of 9.10 ± 8.56 compared with 5.38 ± 5.14 in control patients. MT 
scores increased significantly with age and with smoking in both groups of patients (p < 0.05). Patients with schizo‑
phrenia showed a filled teeth (FT) score of 1.38 ± 2.70 compared with 2.34 ± 3.48 in control patients. FT differences 
in gender and smoking habits between patients with schizophrenia and healthy control subjects were statistically 
significant (p < 0.05). This data, along with the DT scores, suggests that patients with schizophrenia have extensive 
untreated dental disease.
Conclusions: Patients with schizophrenia constitute a high risk population for dental health. This group showed a 
greater prevalence of decayed and missing teeth and more extensive treatment needs.
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Background
The prevalence of mental disorders is high and causes 
profound health, family, social, cultural and economic 
problems worldwide. Schizophrenia is the most complex 
psychiatric disorder that affects mankind [1]. Epidemio-
logically, the incidence of mental disorders in the general 
population is significant (4.5 per 1000 persons), and is 
higher in urban settings in developed nations [2, 3]. The 
majority of people with schizophrenia suffer a variety of 
medical comorbidities (such as emphysema, obesity, lung 
cancer, and cardiac disease) as well as an increased risk of 
death [2–4].
Several studies of the oral health of psychiatric patients 
in different countries have showed that mental illnesses 
and the psychotropic medications used to treat them 
can increase the prevalence and the severity of den-
tal diseases (e.g., caries) [5–20]. Schizophrenia should 
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be considered a risk factor for poor oral health because 
patients with schizophrenia are likely to face a unique set 
of factors that lead to the development of advanced oral 
diseases—and to receive less oral health care [21–28].
Psychotropic medications may cause an important 
salivary gland hypofunction. In fact, decreased saliva-
tion is the oral adverse effect of such medications most 
frequently reported by patients and clinicians. Phe-
nothiazines, atypical antipsychotics, benzodiazepines 
and antiparkinsonians drugs have been shown to cause 
salivary hypofunction and xerostomia in patients with 
schizophrenia [3, 6, 12, 22, 24]. Importantly, patients with 
schizophrenia who experience reduced salivary flow have 
an increased incidence of dental caries [26, 27]. Hyposali-
vation causes the intensification of cariogenic microflora 
because of the adverse changes in the oral environment 
and increases the rapid progression of tooth decay [6, 
10, 12, 14, 16, 22]. Another factor that contributes to 
increased incidence of dental caries in patients with 
schizophrenia is higher sugar intake. Snacking frequency 
is associated with a higher prevalence of dental caries and 
plaque index, and this frequency is higher in this kind of 
patients than in general population [6, 17, 28].
Chronic psychiatric patients with schizophrenia have 
shown a lack of motivation in the maintenance of dental 
hygiene. Negative symptoms and personality disorders of 
mental illness may be responsible for poor tooth brush-
ing habits [11, 23, 24, 28]. Almost all patients with schiz-
ophrenia have large amounts of plaque and calculus and 
high bleeding indices [6, 9, 10, 13, 17, 18]. Smoking habits 
are highly problematic in patients with schizophrenia and 
contribute to worse dental hygiene and increased loss 
of periodontal attachment [16–19, 24, 25]. Tobacco use 
affects the morphology and motility of human gingival 
and periodontal ligament fibroblasts, which facilitate the 
development and progression of periodontal disease. In 
addition, tobacco use is a harmful habit that is associated 
with other non-hygienic habits. Moreover, water pipe 
smoking has been linked with pathological conditions 
such as greater inflammation, candidiasis, periodontitis, 
dry socket, elevated blood chromium and nickel levels, 
premalignant lesions, oral cancer, oesophageal squamous 
cell carcinoma, attic retraction, oedema in the vocal 
cords, and lower habitual vocal pitch and voice turbu-
lence index [29, 30].
People with schizophrenia receive suboptimal oral 
health care and visit dentists less frequently than the gen-
eral population of the same community [25, 26]. Several 
studies of the dental health of these patients have shown 
that they have extensive dental needs, which has a nega-
tive impact on their quality of life [5, 6, 12, 20, 25, 27]. 
Long-term hospitalisation may result in increased oral 
diseases, especially dental caries and periodontal disease, 
because preventive dental care is not an integral part of 
psychiatric care [10, 11, 14–16, 23, 27].
While clinical investigations on the dental health of 
patients with schizophrenia have increased in recent dec-
ades, no specific studies have been conducted to assess 
the frequency and severity of tooth decay in this group of 
patients in relation to the rest of the population. The aim 
of this study was to compare the DMFT scores of patients 
with schizophrenia to those of healthy control patients, 
and to study the possible relationships between dental 
status and different variables.
Methods
The study was conducted with two groups of patients: 
patients with schizophrenia and dental patients without 
mental disorders (the control group). The study was con-
ducted from February 2012 to March 2013. Patients with 
schizophrenia were selected using a random stratified 
method according to age and gender, from a total popula-
tion of 400 patients attending the Psychiatry Department 
at the University Hospital Virgen Macarena in the Fac-
ulty of Medicine of Seville. Diagnosis of schizophrenia 
was established according the international criteria of the 
American Psychiatric Association [31].
The control group was selected from among healthy 
subjects seeking dental treatment at the Faculty of Den-
tistry of Seville. Using the medical surveys of the Faculty, 
we selected only people without any system health prob-
lems (ASA I). Patients taking any medication for any sys-
temic disease or condition in the 6 months prior to the 
study were excluded. The selection of control subjects 
was conducted in consideration of the age and gender of 
the patients recruited previously (case–control study, one 
control for each case). The Research Ethics Committee of 
the University of Seville approved the study, and all par-
ticipants gave their written informed consent.
Patients with schizophrenia, or their legal guardians, 
gave consent to collect the necessary data in this study, 
always preserving the anonymity of the patients. There-
fore, demographic data for the patients with schizo-
phrenia were obtained from their medical records, as 
collected by hospital staff; similar information was gar-
nered directly from the control patients. The demo-
graphic variables include age and gender, and also habit 
smoking, diagnostic psychiatric and taking of drugs.
Dental examinations took place in the Faculty of Den-
tistry of Seville for healthy control patients, and in the 
Psychiatry Department of University Hospital Virgen 
Macarena of Seville for patients with schizophrenia. 
Each patient’s dental status was determined according 
to criteria set by the World Health Organization [32]. 
The decayed, missing and filled teeth (DMFT) score 
was used to assess the dental status of patients. DMFT 
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were assessed in both groups of patients, according to 
demographic (age and sex) and clinical (smoking and 
psychotropic medications) data. All of the dental analy-
ses were performed by the same two operators (EV-O 
and LM-G), and the explorer was always the same 
(EV-O).
Statistical analyses were carried out using SPSS Ver-
sion 17.0 (SPSS Inc., Chicago, IL, USA). Chi square test 
was used to analyse the differences between proportions. 
Analysis of variance (ANOVA) was used to detect differ-
ences between means. Statistical significance was estab-
lished at p < 0.05. A Kolmogorov–Smirnov test was used 
to ensure the normality of data. Sample size was selected 
to identify changes of an amplitude of 1.5 in a quantita-
tive variable (DMFT score), with a power of test of 80%, 
an error alpha of 5%, and a common standard deviation 
of 2.5.
Results
Fifty patients with schizophrenia (39 males and 
11 females) with a mean age of 39.9  years (range: 
18–64 years) were examined, along with 50 healthy con-
trol subjects (33 males and 17 females) with a mean age 
of 39.5 years (range: 20–67 years) (Table 1). Differences 
in age (ANOVA; p = 0.8542) and gender (Chi square test; 
p =  0.18145) between the two groups were not statisti-
cally significant.
All patients with schizophrenia were treated with two 
or more psychotropic drugs (3.9 ±  2.2). Fifty-eight per-
cent of patients were taking more than four psychotropic 
medications. Phenothiazines (72%), atypical antipsychot-
ics (60%), benzodiazepines (50%) and antiparkinsonians 
(50%) were the most common psychotropic drugs used. 
Twenty-nine of the patients with schizophrenia (58%) 
and 26 members of the control group (52%) were smok-
ers (Table  1). Differences in the percentage of smokers 
in the two groups were not statistically significant (Chi 
square; p = 0.12000).
Patients with schizophrenia expressed a mean number 
of decayed teeth (DT) of 7.26  ±  5.69. Healthy controls 
showed a DT of 6.50 ± 4.37 (Table 2). These differences 
were significant (p = 0.0217). Among patients with schiz-
ophrenia, DT scores were highest in 36- to 45-year-old 
patients (8.28  ±  5.22). These differences were not sig-
nificant (p =  0.3368). DT scores among healthy control 
subjects were highest in patients younger than 35  years 
old (7.84 ± 4.69), but did not show significant differences 
(p = 0.0610) (Table 2).
Among patients with schizophrenia, males showed 
higher DT scores (7.69  ±  5.60) compared with females 
(5.72  ±  6.01). These differences were not significant 
(p = 0.3169). Among the healthy control subjects, males 
showed lower DT scores (6.18  ±  4.35) than females 
(7.17  ±  4.47). These differences were not significant 
(p = 0.4522) (Table 2).
In the group of patients with schizophrenia, those 
who smoked showed higher DT scores (9.34  ±  5.42) 
compared with non-smokers (4.38 ± 4.82). These differ-
ences were significant (p = 0.0016). In the healthy control 
group, smokers showed higher DT scores (6.88 ±  4.85) 
compared with non-smokers (6.12 ± 3.85). These differ-
ences were not significant (p = 0.5452) (Table 2).
All 50 of the patients with schizophrenia (100%) 
showed at least one missing tooth. Two patients (4%) 
were totally edentulous. The mean number of missing 
teeth (MT) was 9.10 ± 8.56. Forty-three healthy control 
patients (86%) showed at least one missing tooth, with an 
MT score of 5.38 ± 5.14. These differences were signifi-
cant (p = 0.0098) (Table 2).
MT scores increased significantly with age among 
the patients with schizophrenia (p =  0.0039) and those 
in the control group (p  =  0.0004). Among the patients 
with schizophrenia, females showed higher MT scores 
(9.72 ± 9.85) compared with males (8.92 ± 8.30). These 
differences were not significant (p  =  0.7865). In the 
healthy control group, males showed higher MT scores 
(5.48  ±  5.79) than females (5.17  ±  3.69). These differ-
ences were not significant (p = 0.8432) (Table 2).
In the group of patients with schizophrenia, smok-
ers showed higher MT scores (10.27 ±  8.48) compared 
with non-smokers (7.47 ±  8.62). These differences were 
not significant (p = 0.2583). Among the healthy controls, 
smokers showed higher MT scores (5.92  ±  6.01) com-
pared with non-smokers (4.79 ± 4.04). These differences 
were not significant (p = 0.4427) (Table 2).
Fourteen patients with schizophrenia (28%) showed at 
least one filled tooth. The mean number of filled teeth 
Table 1 Distribution of patients
Patients with schizo-
phrenia
Control
n % n %
Age (years)
 <35 13 26 19 38
 36–45 25 50 17 34
 >46 12 24 14 28
Gender
 Males 39 78 33 66
 Females 11 22 17 34
Smoking
 Smokers 29 58 26 52
 Non‑smokers 21 42 24 48
Total 50 100 50 100
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(FT) among this group was 1.38  ±  2.70. Twenty-five 
healthy control patients (50%) showed at least one filled 
tooth, with an average FT score of 2.34 ± 3.48. These dif-
ferences were not significant (p  =  0.1274). Differences 
in the number of FT among patients with schizophre-
nia with respect to gender (p  =  0.0451) and smoking 
(p = 0.0328) were statistically significant (Table 2).
The mean DMFT of the patients with schizophrenia 
and the healthy control group were 17.74  ±  8.54 and 
14.24  ±  4.85, respectively. DMFT scores increased sig-
nificantly with age for both the patients with schizophre-
nia (p =  0.0027) and the controls (p =  0.0204). DMFT 
differences with respect to smoking (p = 0.0109) among 
patients with schizophrenia were statistically significant 
(Table 2).
Discussion
Before discussing our results, we must assume that our 
study presents some limitations. The selection of sub-
jects without mental disorders for the control group was 
based on a medical questionnaire and the anamnesis of 
the patient. This method carries the risks that a question-
naire could be inaccurate or an individual patient could 
be dishonest. However, the comparison between the two 
groups seems to indicate that the groups are comparable. 
The smoking rate among study subjects was high, and 
this could affect the extrapolation of our results to other 
populations, especially outside of Spain.
Accepting the above, the clinical findings of this study 
demonstrate differences in the prevalence and distribu-
tion of decayed teeth (DT), missing teeth (MT), filled 
teeth (FT) and DMFT between patients with schizophre-
nia and healthy control subjects. Decayed and missing 
teeth were significantly more prevalent in patients with 
schizophrenia, suggesting a lack of restorative care with 
extensive unmet dental treatment needs [6, 16, 23, 24, 27, 
28]. In the present study, the DMFT score of the group 
with schizophrenia was comparable to scores found by 
other studies concerning non-institutionalised patients 
with schizophrenia in Mediterranean countries with 
similar demographic variables [23, 24]. A previous Greek 
study in outpatients with schizophrenia showed a lower 
DMFT (16.08) with a DT score of 2.26, MT score of 9.68 
and FT score of 2.92 [23]. Also, a recent Spanish study 
reported a lower DMFT score (13.51) with a DT score 
of 4.39, MT score of 5.66, and FT score of 3.53 among 
psychiatric patients with schizophrenia [24]. The main 
differences may be explained because the combination 
of decayed teeth and missing teeth in the present study 
resulted in high DMFT values. The FT scores showed a 
lower number of filled teeth. The present study reported 
an MT score of 9.10 ± 8.56 missing teeth among patients 
with schizophrenia, and 40% of these patients were miss-
ing 9-32 teeth. In contrast, the control group had a lower 
MT score (5.38  ±  5.14) with 22% of subjects missing 
9–32 teeth.
The present study indicated significant differences 
in the number and distribution of decayed teeth. DT 
scores were higher in patients with schizophrenia com-
pared with controls. Overall, 44% of patients with schizo-
phrenia and 37% of control subjects showed 8 or more 
decayed teeth. Mental disorders such as schizophrenia 
may be a risk factor for dental health [3, 4]. A relation-
ship between negative psychopathological states and 
higher prevalence of decayed teeth has been evidenced 
[23, 24]. Negative symptoms of schizophrenia impair 
the ability of patients to exercise preventive oral hygiene 
[23]. Moreover, chronically hospitalised patients tend 
Table 2 Distribution of dental status
The data with the same letter show statistical differences (p<0.05)
a–j  Statistically significant differences
Patients with schizophrenia Control
D M F DMFT D M F DMFT
Age (years)
 <35 5.38 ± 3.81 3.92 ± 3.25d 2.61 ± 3.73 11.92 ± 3.70g 7.84 ± 4.69 2.42 ± 2.41i 1.31 ± 2.08 11.57 ± 5.18j
 36–45 8.28 ± 5.22 9.00 ± 7.34d 0.88 ± 2.02 18.16 ± 8.17g 6.88 ± 4.18 5.58 ± 3.58i 3.00 ± 4.10 15.47 ± 3.57j
 >46 7.16 ± 7.89 14.91 ± 11.36d 1.08 ± 2.46 23.16 ± 9.59g 4.28 ± 3.47 9.14 ± 6.90i 2.92 ± 4.06 16.35 ± 6.49j
Gender
 Males 7.69 ± 5.60 8.92 ± 8.30 0.97 ± 2.24e 17.58 ± 9.17 6.18 ± 4.35 5.48 ± 5.79 2.21 ± 3.78 13.87 ± 4.85
 Females 5.72 ± 6.01 9.72 ± 9.85 2.81 ± 3.73e 18.27 ± 6.11 7.17 ± 4.47 5.17 ± 3.69 2.58 ± 2.91 14.94 ± 4.85
Smoking
 Smokers 9.34 ± 5.42c 10.27 ± 8.48 0.68 ± 1.73f 20.31 ± 7.81h 6.88 ± 4.85 5.92 ± 6.01 2.07 ± 3.01 14.88 ± 6.40
 Non‑smokers 4.38 ± 4.82c 7.47 ± 8.62 2.33 ±3.48f 14.19 ± 8.40h 6.12 ± 3.85 4.79 ± 4.04 2.62 ± 3.97 13.54 ± 4.24
Total 7.26 ± 5.69a 9.10 ± 8.56b 1.38 ± 2.70 17.74 ± 8.54 6.50 ± 4.37a 5.38 ± 5.14b 2.34 ± 3.48 14.24 ± 4.85
Page 5 of 7Velasco‑Ortega et al. BMC Res Notes  (2017) 10:50 
to have more severe negative symptoms than patients 
who live in the community [24]. In fact, long-term hos-
pitalisation causes declines in self- and oral hygiene and 
dental care, resulting in increased dental caries [10–16]. 
DMFT scores were higher among hospitalised patients 
with schizophrenia, but these patients were also older 
(range of age of 48–58  years) [10, 12, 14–17, 27]. Sev-
eral studies reporting on hospitalised chronic psychiat-
ric patients with schizophrenia reported high DT scores 
and MT scores and lower FT scores [12–16]. In addition, 
one study showed a lower mean DMFT score of 16.08 in 
outpatients with schizophrenia compared with patients 
with schizophrenia who had been hospitalised for up to 
10  years (18.50) and those hospitalised for more than 
10 years (27.17) [23].
The majority of patients with schizophrenia take psy-
chotropic medications on a regular basis. Relevant medi-
cations include conventional and atypical antipsychotics, 
benzodiazepines and antiparkinsonians [14–16]. Psy-
chotropic medications can contribute to dental caries 
in patients with schizophrenia, as many of them cause 
dry mouth due to reduced salivary flow [3, 6, 12, 16]. An 
American study showed that 99% of smooth surface car-
ies (coronal and root) was associated with low salivary 
flow [6]. Root surface caries, generally associated with 
older populations, were notably high in a group of young 
psychiatric patients with schizophrenia [6]. A Turk-
ish study showed a 39.9% correlation of oral dryness in 
chronic psychiatric patients with the administration of 
these medications [mean: 2.3 (number of medications 
per patient)]. Patients with schizophrenia had the highest 
incidence of symptoms of oral dryness [16]. These find-
ings were confirmed by another study in Israel, where 
94% of inpatient study subjects were taking psycho-
tropic medications [mean 2 (number of medications per 
patient)] and 22% reported experiencing dry mouth [14].
The results showed that the prevalence of missing 
teeth increased significantly with age in both groups. 
For all age groups, the mean number of missing teeth 
(MT) was higher in patients with schizophrenia com-
pared with the control subjects. The schizophrenic group 
showed a significant age-related increase in DMFT with 
a corresponding significant increase in the MT score and 
decrease in the DT component. The mean DMFT score 
in the oldest age group (over 46 years) was approximately 
twice that of the youngest age group (up to 35  years). 
These findings are consistent with those seen in similar 
psychiatric groups demonstrating that age is an impor-
tant determinant of poor oral health [12, 14, 15, 17, 24, 
28]. Among the patients with schizophrenia, the carious 
disease process seems to progress over time, and teeth 
are lost rather than being restored. This is indicated by 
the increases in MT scores over time [12, 14]. The high 
prevalence of missing teeth with age may be interpreted 
to suggest that patients with schizophrenia who seek 
dental care often have their teeth extracted rather than 
seeking restorative treatment, probably because of the 
complexity of their dental care needs [10–14].
In the present study, the gender distribution of the 
patients with schizophrenia (39 males and 11 females) and 
the control subjects (33 males and 17 females) were simi-
lar. In addition, the DMFT scores in this study did not vary 
greatly between males and females. These results are con-
firmed by two similar comparative studies of oral health in 
patients with schizophrenia, also in Spain, which showed 
that gender did not affect the dental parameters measured 
in both study and control groups [20, 24]. A study in Tai-
wan reported the results of DMFT for males and females 
among inpatients with schizophrenia (13.93 vs. 13.98) 
and general patients (7.1 vs. 9.73) with no significant dif-
ferences [27]. Where differences have been reported, men 
have worse dental disease than women [14–17, 20]. In 
patients with schizophrenia, males tend to show higher 
numbers of carious teeth and root remnants caused by 
negligence of dental care compared with females [14, 16].
Most people suffering schizophrenia smoke heavily. 
Smoking is associated with medical and dental prob-
lems in patients with schizophrenia. A comparative study 
showed a significantly higher proportion of smokers in 
patients with schizophrenia (71%) than controls (39%) 
(24). A similar trend in smoking prevalence is observed 
in older patients with schizophrenia (52%) compared 
with older controls (23%) [25]. However, in the present 
study the prevalence of smoking in the schizophrenia 
group (56%) was similar to that in the control group 
(52%). Smoking can contribute to poor dental health as 
it is associated with increased periodontal disease and 
higher rates of tooth loss. Smoking has been related to 
higher DMFT scores in patients with schizophrenia [28]. 
Higher numbers of missing and decayed teeth have been 
reported in smokers compared to non-smokers among 
patients with schizophrenia [24]. These results are con-
firmed by the present study: analyses of each parameter 
individually (D, M and F teeth) revealed that smoking 
affected the number of missing and decayed teeth. The 
D and M values were higher among smokers compared 
with non-smokers. Moreover, the mean DT and MT 
scores were higher in smokers with schizophrenia than in 
the smokers of the control group.
The overall percentage of smokers in Spain is 40% (one 
of the highest rates in Europe) [33]. In our sample, the 
percentage ranged from 50 to 60% in both groups. We do 
not think this invalidates our conclusions, although they 
may not be accurately extrapolated to populations with 
others percentages of smokers, especially given the effect 
that smoking can have on other habits and behaviours.
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Another important finding from this study is the low 
number of filled teeth (FT). Among patients with schizo-
phrenia the number was 1.38 ±  2.70, while in the con-
trol group it was 2.34 ± 3.48. These clinical findings are 
consistent with those of other studies, which have dem-
onstrated that patients with schizophrenia are in need 
of preventive and restorative dental treatment [12, 17, 
20, 23]. Illness chronicity and psychopathology severity 
may explain why patients with schizophrenia visit den-
tists much less frequently than the general population 
[26]. Negative symptomatology may cause patients to 
visit the dentist only when they have severe dental prob-
lems that are difficult to treat [23]. Schizophrenia may 
severely interfere with patients seeking dental treatment, 
delaying restorative treatment until tooth loss is inevi-
table [17]. Moreover, dental diseases often represent a 
lower priority in the overall health care of patients with 
schizophrenia, but these have a negative impact on the 
general quality of life [27]. The use of a multidisciplinary 
model involving mental and oral health is fundamental to 
the development of dental programs. These programmes 
must educate and sensitise psychiatrists and psychiatric 
nurses to dental health. Access to skilled dental care can 
improve most dental problems for patients with schizo-
phrenia [23].
Conclusion
The clinical findings of this study demonstrate that 
patients with schizophrenia should be considered a high-
risk group for dental disease. Patients with schizophrenia 
showed worse dental health than the general population. 
This study found that age and smoking in psychiatric 
patients with schizophrenia are determinants for den-
tal caries. Moreover, this study showed a significant rate 
of missing teeth and confirmed the great need for pre-
ventive and restorative dental treatment in this special 
population.
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